Please visit the Merck media library for images and b-roll of the new Durham facility.

NEW YORK, March 27 (Reuters) - Merck & Co (MRK.N), opens new tab said on Thursday that it plans to launch a subcutaneously injected version of its blockbuster cancer immunotherapy Keytruda in the ...

Please visit the Merck media library for images and b-roll of the new Durham facility. About Merck At Merck, known as MSD outside of the United States and Canada, we are unified around our purpose: We ...